Victory Square Updates Hydreight After FDA Peptide Panel Vote
VANCOUVER, BC, July 29, 2026 Victory Square Technologies Inc. has provided an update on Hydreight Technologies and its broader...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
VANCOUVER, BC, July 29, 2026 Victory Square Technologies Inc. has provided an update on Hydreight Technologies and its broader...
BURLINGTON, Mass., July 20, 2026 Consano Bio has announced that the U.S. Food and Drug Administration (FDA) has granted...
WASHINGTON, July 17, 2026 The American Pharmacists Association (APhA) has called on the U.S. Food and Drug Administration (FDA)...
